{"bundle_type":"pith_open_graph_bundle","bundle_version":"1.0","pith_number":"pith:2016:PKNMWZHNY6WWFC3IRNFHZI2UE6","short_pith_number":"pith:PKNMWZHN","canonical_record":{"source":{"id":"1603.00349","kind":"arxiv","version":2},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"math.OC","submitted_at":"2016-02-29T03:30:58Z","cross_cats_sorted":["q-bio.TO"],"title_canon_sha256":"619b8d456d744e06a90d77a5f3fb061a160d6be127f92ad110966e26acc1972d","abstract_canon_sha256":"78b63e227c38090556bff7847a1c941db8584b9d668abf3bafd3561fe97d99bb"},"schema_version":"1.0"},"canonical_sha256":"7a9acb64edc7ad628b688b4a7ca35427bc7d2dedf9dff0d0a0ddbf2d7791d097","source":{"kind":"arxiv","id":"1603.00349","version":2},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1603.00349","created_at":"2026-05-18T00:58:55Z"},{"alias_kind":"arxiv_version","alias_value":"1603.00349v2","created_at":"2026-05-18T00:58:55Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1603.00349","created_at":"2026-05-18T00:58:55Z"},{"alias_kind":"pith_short_12","alias_value":"PKNMWZHNY6WW","created_at":"2026-05-18T12:30:39Z"},{"alias_kind":"pith_short_16","alias_value":"PKNMWZHNY6WWFC3I","created_at":"2026-05-18T12:30:39Z"},{"alias_kind":"pith_short_8","alias_value":"PKNMWZHN","created_at":"2026-05-18T12:30:39Z"}],"events":[{"event_type":"record_created","subject_pith_number":"pith:2016:PKNMWZHNY6WWFC3IRNFHZI2UE6","target":"record","payload":{"canonical_record":{"source":{"id":"1603.00349","kind":"arxiv","version":2},"metadata":{"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"math.OC","submitted_at":"2016-02-29T03:30:58Z","cross_cats_sorted":["q-bio.TO"],"title_canon_sha256":"619b8d456d744e06a90d77a5f3fb061a160d6be127f92ad110966e26acc1972d","abstract_canon_sha256":"78b63e227c38090556bff7847a1c941db8584b9d668abf3bafd3561fe97d99bb"},"schema_version":"1.0"},"canonical_sha256":"7a9acb64edc7ad628b688b4a7ca35427bc7d2dedf9dff0d0a0ddbf2d7791d097","receipt":{"kind":"pith_receipt","key_id":"pith-v1-2026-05","algorithm":"ed25519","signed_at":"2026-05-18T00:58:55.355755Z","signature_b64":"3XKYJbquCIY+tVeg55xW42wT7ImnFmC5cJcbHPfgNrEzxpiW66+/gSJJsVSnpPoH0TjVWQvOej769tgbgV8pDw==","signed_message":"canonical_sha256_bytes","builder_version":"pith-number-builder-2026-05-17-v1","receipt_version":"0.3","canonical_sha256":"7a9acb64edc7ad628b688b4a7ca35427bc7d2dedf9dff0d0a0ddbf2d7791d097","last_reissued_at":"2026-05-18T00:58:55.355217Z","signature_status":"signed_v1","first_computed_at":"2026-05-18T00:58:55.355217Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"source_kind":"arxiv","source_id":"1603.00349","source_version":2,"attestation_state":"computed"},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T00:58:55Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"+3Or5XYL7o7o7GeZoVOSmP+hnMCd/tNgwR+pbs14Vcyyrj2h/wKEnPV2OJKM4C07rt82UKpdRkC/K0zRiFFkAw==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-05-29T22:56:03.797062Z"},"content_sha256":"4153fc19dda47382b2a6b1b765f1070a40a1223e419511327f2795ed59864858","schema_version":"1.0","event_id":"sha256:4153fc19dda47382b2a6b1b765f1070a40a1223e419511327f2795ed59864858"},{"event_type":"graph_snapshot","subject_pith_number":"pith:2016:PKNMWZHNY6WWFC3IRNFHZI2UE6","target":"graph","payload":{"graph_snapshot":{"paper":{"title":"Optimizing chemoradiotherapy to target multi-site metastatic disease and tumor growth","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","headline":"","cross_cats":["q-bio.TO"],"primary_cat":"math.OC","authors_text":"Ehsan Salari, Hamidreza Badri, Kevin Leder, Yoichi Watanabe","submitted_at":"2016-02-29T03:30:58Z","abstract_excerpt":"The majority of cancer-related fatalities are due to metastatic disease. In chemoradiotherapy, chemotherapeutic agents are administered along with radiation to increase damage to the primary tumor and control systemic disease such as metastasis. This work introduces a mathematical model to obtain optimal drug and radiation protocols in a chemoradiotherapy scheduling problem with the objective of minimizing metastatic cancer cell populations at multiple potential sites while maintaining a minimum level of damage to the primary tumor site. We derive closed-form expressions for an optimal chemoth"},"claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1603.00349","kind":"arxiv","version":2},"verdict":{"id":null,"model_set":{},"created_at":null,"strongest_claim":"","one_line_summary":"","pipeline_version":null,"weakest_assumption":"","pith_extraction_headline":""},"references":{"count":0,"sample":[],"resolved_work":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","internal_anchors":0},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"author_claims":{"count":0,"strong_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"builder_version":"pith-number-builder-2026-05-17-v1"},"verdict_id":null},"signer":{"signer_id":"pith.science","signer_type":"pith_registry","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54"},"created_at":"2026-05-18T00:58:55Z","supersedes":[],"prev_event":null,"signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"HytKg0Ubi5RmjhuIEazAukCiMndjdq3prAkaQ0ezor2nEAXMZFOj7Dcofa5w8QVWgOXFidkMOimObswKB+IgCg==","signed_message":"open_graph_event_sha256_bytes","signed_at":"2026-05-29T22:56:03.798056Z"},"content_sha256":"429bf9ad652679007ad1c29e1771bc9010c53d0506dd89120f7b91299aa2de8f","schema_version":"1.0","event_id":"sha256:429bf9ad652679007ad1c29e1771bc9010c53d0506dd89120f7b91299aa2de8f"}],"timestamp_proofs":[],"mirror_hints":[{"mirror_type":"https","name":"Pith Resolver","base_url":"https://pith.science","bundle_url":"https://pith.science/pith/PKNMWZHNY6WWFC3IRNFHZI2UE6/bundle.json","state_url":"https://pith.science/pith/PKNMWZHNY6WWFC3IRNFHZI2UE6/state.json","well_known_bundle_url":"https://pith.science/.well-known/pith/PKNMWZHNY6WWFC3IRNFHZI2UE6/bundle.json","status":"primary"}],"public_keys":[{"key_id":"pith-v1-2026-05","algorithm":"ed25519","format":"raw","public_key_b64":"stVStoiQhXFxp4s2pdzPNoqVNBMojDU/fJ2db5S3CbM=","public_key_hex":"b2d552b68890857171a78b36a5dccf368a953413288c353f7c9d9d6f94b709b3","fingerprint_sha256_b32_first128bits":"RVFV5Z2OI2J3ZUO7ERDEBCYNKS","fingerprint_sha256_hex":"8d4b5ee74e4693bcd1df2446408b0d54","rotates_at":null,"url":"https://pith.science/pith-signing-key.json","notes":"Pith uses this Ed25519 key to sign canonical record SHA-256 digests. Verify with: ed25519_verify(public_key, message=canonical_sha256_bytes, signature=base64decode(signature_b64))."}],"merge_version":"pith-open-graph-merge-v1","built_at":"2026-05-29T22:56:03Z","links":{"resolver":"https://pith.science/pith/PKNMWZHNY6WWFC3IRNFHZI2UE6","bundle":"https://pith.science/pith/PKNMWZHNY6WWFC3IRNFHZI2UE6/bundle.json","state":"https://pith.science/pith/PKNMWZHNY6WWFC3IRNFHZI2UE6/state.json","well_known_bundle":"https://pith.science/.well-known/pith/PKNMWZHNY6WWFC3IRNFHZI2UE6/bundle.json"},"state":{"state_type":"pith_open_graph_state","state_version":"1.0","pith_number":"pith:2016:PKNMWZHNY6WWFC3IRNFHZI2UE6","merge_version":"pith-open-graph-merge-v1","event_count":2,"valid_event_count":2,"invalid_event_count":0,"equivocation_count":0,"current":{"canonical_record":{"metadata":{"abstract_canon_sha256":"78b63e227c38090556bff7847a1c941db8584b9d668abf3bafd3561fe97d99bb","cross_cats_sorted":["q-bio.TO"],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"math.OC","submitted_at":"2016-02-29T03:30:58Z","title_canon_sha256":"619b8d456d744e06a90d77a5f3fb061a160d6be127f92ad110966e26acc1972d"},"schema_version":"1.0","source":{"id":"1603.00349","kind":"arxiv","version":2}},"source_aliases":[{"alias_kind":"arxiv","alias_value":"1603.00349","created_at":"2026-05-18T00:58:55Z"},{"alias_kind":"arxiv_version","alias_value":"1603.00349v2","created_at":"2026-05-18T00:58:55Z"},{"alias_kind":"doi","alias_value":"10.48550/arxiv.1603.00349","created_at":"2026-05-18T00:58:55Z"},{"alias_kind":"pith_short_12","alias_value":"PKNMWZHNY6WW","created_at":"2026-05-18T12:30:39Z"},{"alias_kind":"pith_short_16","alias_value":"PKNMWZHNY6WWFC3I","created_at":"2026-05-18T12:30:39Z"},{"alias_kind":"pith_short_8","alias_value":"PKNMWZHN","created_at":"2026-05-18T12:30:39Z"}],"graph_snapshots":[{"event_id":"sha256:429bf9ad652679007ad1c29e1771bc9010c53d0506dd89120f7b91299aa2de8f","target":"graph","created_at":"2026-05-18T00:58:55Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"graph_snapshot":{"author_claims":{"count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57","strong_count":0},"builder_version":"pith-number-builder-2026-05-17-v1","claims":{"count":0,"items":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"formal_canon":{"evidence_count":0,"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"paper":{"abstract_excerpt":"The majority of cancer-related fatalities are due to metastatic disease. In chemoradiotherapy, chemotherapeutic agents are administered along with radiation to increase damage to the primary tumor and control systemic disease such as metastasis. This work introduces a mathematical model to obtain optimal drug and radiation protocols in a chemoradiotherapy scheduling problem with the objective of minimizing metastatic cancer cell populations at multiple potential sites while maintaining a minimum level of damage to the primary tumor site. We derive closed-form expressions for an optimal chemoth","authors_text":"Ehsan Salari, Hamidreza Badri, Kevin Leder, Yoichi Watanabe","cross_cats":["q-bio.TO"],"headline":"","license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"math.OC","submitted_at":"2016-02-29T03:30:58Z","title":"Optimizing chemoradiotherapy to target multi-site metastatic disease and tumor growth"},"references":{"count":0,"internal_anchors":0,"resolved_work":0,"sample":[],"snapshot_sha256":"258153158e38e3291e3d48162225fcdb2d5a3ed65a07baac614ab91432fd4f57"},"source":{"id":"1603.00349","kind":"arxiv","version":2},"verdict":{"created_at":null,"id":null,"model_set":{},"one_line_summary":"","pipeline_version":null,"pith_extraction_headline":"","strongest_claim":"","weakest_assumption":""}},"verdict_id":null}}],"author_attestations":[],"timestamp_anchors":[],"storage_attestations":[],"citation_signatures":[],"replication_records":[],"corrections":[],"mirror_hints":[],"record_created":{"event_id":"sha256:4153fc19dda47382b2a6b1b765f1070a40a1223e419511327f2795ed59864858","target":"record","created_at":"2026-05-18T00:58:55Z","signer":{"key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signer_id":"pith.science","signer_type":"pith_registry"},"payload":{"attestation_state":"computed","canonical_record":{"metadata":{"abstract_canon_sha256":"78b63e227c38090556bff7847a1c941db8584b9d668abf3bafd3561fe97d99bb","cross_cats_sorted":["q-bio.TO"],"license":"http://arxiv.org/licenses/nonexclusive-distrib/1.0/","primary_cat":"math.OC","submitted_at":"2016-02-29T03:30:58Z","title_canon_sha256":"619b8d456d744e06a90d77a5f3fb061a160d6be127f92ad110966e26acc1972d"},"schema_version":"1.0","source":{"id":"1603.00349","kind":"arxiv","version":2}},"canonical_sha256":"7a9acb64edc7ad628b688b4a7ca35427bc7d2dedf9dff0d0a0ddbf2d7791d097","receipt":{"algorithm":"ed25519","builder_version":"pith-number-builder-2026-05-17-v1","canonical_sha256":"7a9acb64edc7ad628b688b4a7ca35427bc7d2dedf9dff0d0a0ddbf2d7791d097","first_computed_at":"2026-05-18T00:58:55.355217Z","key_id":"pith-v1-2026-05","kind":"pith_receipt","last_reissued_at":"2026-05-18T00:58:55.355217Z","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","receipt_version":"0.3","signature_b64":"3XKYJbquCIY+tVeg55xW42wT7ImnFmC5cJcbHPfgNrEzxpiW66+/gSJJsVSnpPoH0TjVWQvOej769tgbgV8pDw==","signature_status":"signed_v1","signed_at":"2026-05-18T00:58:55.355755Z","signed_message":"canonical_sha256_bytes"},"source_id":"1603.00349","source_kind":"arxiv","source_version":2}}},"equivocations":[],"invalid_events":[],"applied_event_ids":["sha256:4153fc19dda47382b2a6b1b765f1070a40a1223e419511327f2795ed59864858","sha256:429bf9ad652679007ad1c29e1771bc9010c53d0506dd89120f7b91299aa2de8f"],"state_sha256":"c759035da6fc3a2c743f0d6a6783b3e84851c205df8ff5e351f2437e087f764c"},"bundle_signature":{"signature_status":"signed_v1","algorithm":"ed25519","key_id":"pith-v1-2026-05","public_key_fingerprint":"8d4b5ee74e4693bcd1df2446408b0d54","signature_b64":"3/rVSbo8KRoy9JPltws7U2vu+diOrfHji4BaqeyQqT3fGPF3ql3Ba8xs6AS2pOsjJYOj0z1lAI5feopuwbIjBw==","signed_message":"bundle_sha256_bytes","signed_at":"2026-05-29T22:56:03.801856Z","bundle_sha256":"102358cf34332db3fd6de5e5a01086a49bd509432677ecb6c0119d1256bca35c"}}